Daniel E. Geffken - 07 Jun 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role: Director
Signature: /s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol: WINT
Transactions as of: 07 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2022, 20:13:42 UTC
Previous filing: 01 Dec 2021
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WINT	Common Stock	Award	$0	+5,000	+242%	$0.000000	7,069	07 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WINT	Stock Option (Right to Buy)	Award	$0	+7,500		$0.000000	7,500	07 Jun 2022	Common Stock	7,500	$0.4700	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.
F2	The stock option shall vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) Windtree's subsequent annual meeting of stockholders, provided that the reporting person remains in continuous service through the vesting date.